Literature DB >> 25314817

Factors influencing survivorship of rehabilitating green sea turtles (Chelonia mydas) with fibropapillomatosis.

Annie Page-Karjian, Terry M Norton, Paula Krimer, Maya Groner, Steven E Nelson, Nicole L Gottdenker.   

Abstract

Marine turtle fibropapillomatosis (FP) is a debilitating, infectious neoplastic disease that has reached epizootic proportions in several tropical and subtropical populations of green turtles (Chelonia mydas). FP represents an important health concern in sea turtle rehabilitation facilities. The objectives of this study were to describe the observed epidemiology, biology, and survival rates of turtles affected by FP (FP+ turtles) in a rehabilitation environment; to evaluate clinical parameters as predictors of survival in affected rehabilitating turtles; and to provide information about case progression scenarios and potential outcomes for FP+ sea turtle patients. A retrospective case series analysis was performed using the medical records of the Georgia Sea Turtle Center (GSTC), Jekyll Island, Georgia, USA, during 2009-2013. Information evaluated included signalment, morphometrics, presenting complaint, time to FP onset, tumor score (0-3), co-morbid conditions, diagnostic test results, therapeutic interventions, and case outcomes. Overall, FP was present in 27/362 (7.5%) of all sea turtles admitted to the GSTC for rehabilitation, either upon admittance or during their rehabilitation. Of these, 25 were green and 2 were Kemp's ridley turtles. Of 10 turtles that had only plaque-like FP lesions, 60% had natural tumor regression, all were released, and they were significantly more likely to survive than those with classic FP (P = 0.02 [0.27-0.75, 95% CI]). Turtles without ocular FP were eight times more likely to survive than those with ocular FP (odds ratio = 8.75, P = 0.032 [1.21-63.43, 95% CI]). Laser-mediated tumor removal surgery is the treatment of choice for FP+ patients at the GSTC; number of surgeries was not significantly related to case outcome.

Entities:  

Mesh:

Year:  2014        PMID: 25314817     DOI: 10.1638/2013-0132R1.1

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  11 in total

1.  Health assessment of juvenile green turtles in southern São Paulo State, Brazil: a hematologic approach.

Authors:  Daniela M D de Mello; Maria C L Alvarez
Journal:  J Vet Diagn Invest       Date:  2019-12-17       Impact factor: 1.279

2.  Preparation of recombinant glycoprotein B (gB) of Chelonid herpesvirus 5 (ChHV5) for antibody production and its application for infection detection in sea turtles.

Authors:  Tsung-Hsien Li; Wei-Li Hsu; Chang-You Chen; Yi-Chen Chen; Yu-Chen Wang; Ming-An Tsai; I-Chun Chen; Chao-Chin Chang
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

3.  Influence of Sunlight on Vitamin D and Health Status in Green (Chelonia mydas) Sea Turtles with Fibropapillomatosis.

Authors:  Victoria E Garefino; Sarah L Milton
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

4.  Examining the Role of Transmission of Chelonid Alphaherpesvirus 5.

Authors:  Andrea Chaves; A Alonso Aguirre; Kinndle Blanco-Peña; Andrés Moreira-Soto; Otto Monge; Ana M Torres; José L Soto-Rivas; Yuanan Lu; Didiher Chacón; Luis Fonseca; Mauricio Jiménez; Gustavo Gutiérrez-Espeleta; Michael Lierz
Journal:  Ecohealth       Date:  2017-05-16       Impact factor: 3.184

5.  Environmental DNA monitoring of oncogenic viral shedding and genomic profiling of sea turtle fibropapillomatosis reveals unusual viral dynamics.

Authors:  Jessica A Farrell; Kelsey Yetsko; Liam Whitmore; Jenny Whilde; Catherine B Eastman; Devon Rollinson Ramia; Rachel Thomas; Paul Linser; Simon Creer; Brooke Burkhalter; Christine Schnitzler; David J Duffy
Journal:  Commun Biol       Date:  2021-05-12

6.  Molecular characterization of a marine turtle tumor epizootic, profiling external, internal and postsurgical regrowth tumors.

Authors:  Kelsey Yetsko; Jessica A Farrell; Nicholas B Blackburn; Liam Whitmore; Maximilian R Stammnitz; Jenny Whilde; Catherine B Eastman; Devon Rollinson Ramia; Rachel Thomas; Aleksandar Krstic; Paul Linser; Simon Creer; Gary Carvalho; Mariana A Devlin; Nina Nahvi; Ana Cristina Leandro; Thomas W deMaar; Brooke Burkhalter; Elizabeth P Murchison; Christine Schnitzler; David J Duffy
Journal:  Commun Biol       Date:  2021-02-01

7.  Transcriptomic Profiling of Fibropapillomatosis in Green Sea Turtles (Chelonia mydas) From South Texas.

Authors:  Nicholas B Blackburn; Ana Cristina Leandro; Nina Nahvi; Mariana A Devlin; Marcelo Leandro; Ignacio Martinez Escobedo; Juan M Peralta; Jeff George; Brian A Stacy; Thomas W deMaar; John Blangero; Megan Keniry; Joanne E Curran
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

8.  Challenges in Evaluating the Severity of Fibropapillomatosis: A Proposal for Objective Index and Score System for Green Sea Turtles (Chelonia mydas) in Brazil.

Authors:  Silmara Rossi; Angélica María Sánchez-Sarmiento; Ralph Eric Thijl Vanstreels; Robson Guimarães Dos Santos; Fabiola Eloisa Setim Prioste; Marco Aurélio Gattamorta; José Henrique Hildebrand Grisi-Filho; Eliana Reiko Matushima
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

9.  Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers.

Authors:  David J Duffy; Christine Schnitzler; Lorraine Karpinski; Rachel Thomas; Jenny Whilde; Catherine Eastman; Calvin Yang; Aleksandar Krstic; Devon Rollinson; Bette Zirkelbach; Kelsey Yetsko; Brooke Burkhalter; Mark Q Martindale
Journal:  Commun Biol       Date:  2018-06-07

10.  Insights on Immune Function in Free-Ranging Green Sea Turtles (Chelonia mydas) with and without Fibropapillomatosis.

Authors:  Justin R Perrault; Milton Levin; Cody R Mott; Caitlin M Bovery; Michael J Bresette; Ryan M Chabot; Christopher R Gregory; Jeffrey R Guertin; Sarah E Hirsch; Branson W Ritchie; Steven T Weege; Ryan C Welsh; Blair E Witherington; Annie Page-Karjian
Journal:  Animals (Basel)       Date:  2021-03-18       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.